In late August 2015, the Health Resources and Services Administration (HRSA) released highly anticipated proposed guidance for its 340B Drug Pricing Program, which has caused uncertainty for the program’s thousands of participants—including Critical Access Hospitals—if it finalizes the proposed Omnibus Guidance. The 340B Program traces its roots to the Veteran’s […]
Health Law Alert
Nebraska Providers: NDHHS Requests for Maternal and Infant Drug Testing and Notification
Recently, many health care providers have received letters from the Nebraska Department of Health and Human Services, Division of Children and Family Services (“CFS”) regarding expectant mothers who CFS believes to be drug users. The letter includes the mother’s name and due date and asks the provider to notify CFS […]
The EMV Liability Shift – What Is It and Why Is It Important
Over the last few weeks, you may have received information from vendors or seen segments on the news regarding the adoption of the EMV standard by the payments industry. While many in the industry have a clear understanding of what EMV is and how it might impact business, for small […]
NY Federal Judge Rules on False Claims Act’s 60-Day Rule
The August 3, 2015 ruling in Kane ex rel. United States et al. v. Healthfirst et al. is the first judicial interpretation of the 60-day rule under the federal False Claims Act. Many seminar hours have been spent among health lawyers as they sought to understand what it would take […]
Office for Civil Rights Announces Consolidation
On June 16, 2015, the Department of Health and Human Services announced a reorganization of its regional offices which will have a significant effect on our clients. The former Region VII Office, located in Kansas City, Missouri (which previously covered Nebraska, Iowa, Kansas, and Missouri), has now been consolidated into […]